REGENXBIO Announces Presentation at the Virtual SVB Securities Global Biopharma Conference
ROCKVILLE, Md., Feb. 8, 2023 /PRNewswire/ — REGENXBIO Inc. (Nasdaq: RGNX) today announced that it will present at the SVB Securities Global Biopharma Conference on Thursday, February 16, 2023. SVB Securities Global Biopharma Conference Date: Thursday, February 16, 2023 Presentation:…
Comments Off on REGENXBIO Announces Presentation at the Virtual SVB Securities Global Biopharma Conference